Latest Issue

Making a better world

Big Pharma should be given a financial incentive to produce the right drugs at the right price

By Philip Ball   October 2010

Millions of people across the world cannot afford the drugs they need. A new business model for the pharmaceutical industry could help

No one can honestly deny the positive impact of modern medicine on our lives. Thanks to antibiotics and routine operations, childbirth and catching bacterial pneumonia are no longer life-threatening events. From bipolar disorder to hypertension and Parkinson’s, drugs ease or eliminate conditions that would be excruciating, debilitating or fatal. Yet most people in the world are still too poor to pay for such drugs. Millions die each year from diseases that we already know how to treat, and…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to

More From Prospect